BP974
Carbamazepine
British Pharmacopoeia (BP) Reference Standard
Manufacturer: Sigma Aldrich
CAS Number: 298-46-4
Synonym(S): 5H-Dibenz[b,f]azepine-5-carboxamide
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 200 MG | BP974-200-MG | In Stock | ₹ 23,641.80 |
BP974 - 200 MG
In Stock
Quantity
1
Base Price: ₹ 23,641.80
GST (18%): ₹ 4,255.524
Total Price: ₹ 27,897.324
grade
pharmaceutical primary standard
API family
carbamazepine
form
solid
shelf life
limited shelf life, expiry date on the label
manufacturer/tradename
BP
mp
191-192 °C (lit.)
application(s)
pharmaceuticalpharmaceutical small molecule
format
neat
storage temp.
2-8°C
SMILES string
NC(=O)N1c2ccccc2C=Cc3ccccc13
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
Medchemexpress LLC HY-B0246 100mg , Carbamazepine CAS:298-46-4 Purity:>98% | -- | ₹ 4,205.25 | ||
U.S. Pharmacopeia Carbamazepine, 298-46-4, MFCD00005073, 100 mg | -- | ₹ 30,854.52 | ||
Carbamazepine, Analytical Standard, ≥99.0% (HPLC), MilliporeSigma™ Supelco™ | -- | ₹ 9,122.50 | ||
Carbamazepine Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™ | -- | ₹ 11,570.00 | ||
CERILLIANT™ Carbamazepine Solution, 1.0 mg/mL in methanol, Sold by MilliporeSigma™ Supelco™ | -- | ₹ 3,956.05 | ||
Sigma Aldrich Fine Chemicals Biosciences Carbamazepine | 298-46-4 | MFCD00005073 | 1g | -- | ₹ 4,708.10 | ||
Sigma Aldrich Fine Chemicals Biosciences Carbamazepine meets USP testing specifications | 298-46-4 | MFCD00005073 | 5G | -- | ₹ 11,992.75 | ||
Carbamazepine | -- | ₹ 10,153.85 | ||
Carbamazepine solution | -- | ₹ 3,803.80 | ||
Carbamazepine | -- | ₹ 40,756.13 |
Related Products
Description
- General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
- Application: Carbamazepine BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia. Also used in monographs such as:Lamotrigine TabletsLamotrigine Dispersible TabletsCarbamazepine Oral SuspensionCarbamazepine Chewable TabletsCarbamazepine TabletsCarbamazepine Prolonged-release Tablets
- Biochem/physiol Actions: Anticonvulsant; ligand for the GABAA receptor benzodiazepine modulatory site. Sodium channel inhibitor.
- Packaging: Unit quantity: 200 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia
- Other Notes: Sales restrictions may apply.
SAFETY INFORMATION
Pictograms
Signal Word
Danger
Hazard Statements
Precautionary Statements
P202 - P261 - P280 - P301 + P312 - P302 + P352 - P308 + P313
Hazard Classifications
Acute Tox. 4 Oral - Repr. 1A - Resp. Sens. 1 - Skin Sens. 1A - STOT SE 3
Target Organs
Central nervous system
WGK
WGK 2
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable